Mannino David M, Sonia Buist A, Vollmer William M
Division of Pulmonary and Critical Care Medicine, University of Kentucky Medical Center, 740 S Limestone, K-528, Lexington, KY 40536, USA.
Thorax. 2007 Mar;62(3):237-41. doi: 10.1136/thx.2006.068379. Epub 2006 Nov 7.
The Global Initiative on Obstructive Lung Disease stages for chronic obstructive pulmonary disease (COPD) uses a fixed ratio of the post-bronchodilator forced expiratory volume in 1 second (FEV(1))/forced vital capacity (FVC) of 0.70 as a threshold. Since the FEV(1)/FVC ratio declines with age, using the fixed ratio to define COPD may "overdiagnose" COPD in older populations.
To determine morbidity and mortality among older adults whose FEV(1)/FVC is less than 0.70 but more than the lower limit of normal (LLN).
The severity of COPD was classified in 4965 participants aged > or =65 years in the Cardiovascular Health Study using these two methods and the age-adjusted proportion of the population who had died or had a COPD-related hospitalisation in up to 11 years of follow-up was determined.
1621 (32.6%) subjects died and 935 (18.8%) had at least one COPD-related hospitalisation during the follow-up period. Subjects (n = 1134) whose FEV(1)/FVC fell between the LLN and the fixed ratio had an increased adjusted risk of death (hazard ratio (HR) 1.3, 95% CI 1.1 to 1.5) and COPD-related hospitalisation (HR 2.6, 95% CI 2.0 to 3.3) during follow-up compared with asymptomatic individuals with normal lung function.
In this cohort, subjects classified as "normal" using the LLN but abnormal using the fixed ratio were more likely to die and to have a COPD-related hospitalisation during follow-up. This suggests that a fixed FEV(1)/FVC ratio of <0.70 may identify at-risk patients, even among older adults.
慢性阻塞性肺疾病(COPD)的全球倡议组织(Global Initiative on Obstructive Lung Disease)制定的COPD分期,使用支气管扩张剂后1秒用力呼气容积(FEV₁)/用力肺活量(FVC)的固定比值0.70作为阈值。由于FEV₁/FVC比值随年龄下降,使用该固定比值来定义COPD可能会在老年人群中“过度诊断”COPD。
确定FEV₁/FVC小于0.70但高于正常下限(LLN)的老年人的发病率和死亡率。
在心血管健康研究中,使用这两种方法对4965名年龄≥65岁的参与者的COPD严重程度进行分类,并确定在长达11年的随访中死亡或有COPD相关住院治疗的人群的年龄调整比例。
在随访期间,1621名(32.6%)受试者死亡,935名(18.8%)至少有一次COPD相关住院治疗。FEV₁/FVC在LLN和固定比值之间的受试者(n = 1134),与肺功能正常的无症状个体相比,随访期间死亡(风险比[HR] 1.3,95%置信区间1.1至1.5)和COPD相关住院治疗(HR 2.6,95%置信区间2.0至3.3)的调整后风险增加。
在该队列中,使用LLN分类为“正常”但使用固定比值分类为异常的受试者在随访期间更有可能死亡和有COPD相关住院治疗。这表明FEV₁/FVC固定比值<0.70可能识别出高危患者,即使在老年人中也是如此。